Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402876/
https://www.ncbi.nlm.nih.gov/pubmed/28458569
http://dx.doi.org/10.2147/CEOR.S138166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402876/
https://www.ncbi.nlm.nih.gov/pubmed/28458569
http://dx.doi.org/10.2147/CEOR.S138166

Ejemplares similares